TY - JOUR
T1 - Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases
AU - Genomics England Research Consortium
AU - Wopperer, Florian J.
AU - Knaup, Karl X.
AU - Stanzick, Kira J.
AU - Schneider, Karen
AU - Jobst-Schwan, Tilman
AU - Ekici, Arif B.
AU - Uebe, Steffen
AU - Wenzel, Andrea
AU - Schliep, Stefan
AU - Schürfeld, Carsten
AU - Seitz, Randolf
AU - Bernhardt, Wanja
AU - Gödel, Markus
AU - Wiesener, Antje
AU - Popp, Bernt
AU - Stark, Klaus J.
AU - Gröne, Hermann Josef
AU - Friedrich, Björn
AU - Weiß, Martin
AU - Basic-Jukic, Nikolina
AU - Schiffer, Mario
AU - Schröppel, Bernd
AU - Huettel, Bruno
AU - Beck, Bodo B.
AU - Sayer, John A.
AU - Ziegler, Christine
AU - Büttner-Herold, Maike
AU - Amann, Kerstin
AU - Heid, Iris M.
AU - Reis, André
AU - Pasutto, Francesca
AU - Wiesener, Michael S.
N1 - Publisher Copyright:
© 2022 International Society of Nephrology
PY - 2022/8
Y1 - 2022/8
N2 - Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) is caused by mutations in one of at least five genes and leads to kidney failure usually in mid adulthood. Throughout the literature, variable numbers of families have been reported, where no mutation can be found and therefore termed ADTKD-not otherwise specified. Here, we aim to clarify the genetic cause of their diseases in our ADTKD registry. Sequencing for all known ADTKD genes was performed, followed by SNaPshot minisequencing for the dupC (an additional cytosine within a stretch of seven cytosines) mutation of MUC1. A virtual panel containing 560 genes reported in the context of kidney disease (nephrome) and exome sequencing were then analyzed sequentially. Variants were validated and tested for segregation. In 29 of the 45 registry families, mutations in known ADTKD genes were found, mostly in MUC1. Sixteen families could then be termed ADTKD-not otherwise specified, of which nine showed diagnostic variants in the nephrome (four in COL4A5, two in INF2 and one each in COL4A4, PAX2, SALL1 and PKD2). In the other seven families, exome sequencing analysis yielded potential disease associated variants in novel candidate genes for ADTKD; evaluated by database analyses and genome-wide association studies. For the great majority of our ADTKD registry we were able to reach a molecular genetic diagnosis. However, a small number of families are indeed affected by diseases classically described as a glomerular entity. Thus, incomplete clinical phenotyping and atypical clinical presentation may have led to the classification of ADTKD. The identified novel candidate genes by exome sequencing will require further functional validation.
AB - Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) is caused by mutations in one of at least five genes and leads to kidney failure usually in mid adulthood. Throughout the literature, variable numbers of families have been reported, where no mutation can be found and therefore termed ADTKD-not otherwise specified. Here, we aim to clarify the genetic cause of their diseases in our ADTKD registry. Sequencing for all known ADTKD genes was performed, followed by SNaPshot minisequencing for the dupC (an additional cytosine within a stretch of seven cytosines) mutation of MUC1. A virtual panel containing 560 genes reported in the context of kidney disease (nephrome) and exome sequencing were then analyzed sequentially. Variants were validated and tested for segregation. In 29 of the 45 registry families, mutations in known ADTKD genes were found, mostly in MUC1. Sixteen families could then be termed ADTKD-not otherwise specified, of which nine showed diagnostic variants in the nephrome (four in COL4A5, two in INF2 and one each in COL4A4, PAX2, SALL1 and PKD2). In the other seven families, exome sequencing analysis yielded potential disease associated variants in novel candidate genes for ADTKD; evaluated by database analyses and genome-wide association studies. For the great majority of our ADTKD registry we were able to reach a molecular genetic diagnosis. However, a small number of families are indeed affected by diseases classically described as a glomerular entity. Thus, incomplete clinical phenotyping and atypical clinical presentation may have led to the classification of ADTKD. The identified novel candidate genes by exome sequencing will require further functional validation.
KW - ADTKD
KW - Alport syndrome
KW - MITKD
KW - MUC1
KW - UMOD
KW - exome
UR - https://www.scopus.com/pages/publications/85133323226
U2 - 10.1016/j.kint.2022.04.031
DO - 10.1016/j.kint.2022.04.031
M3 - Article
C2 - 35643372
AN - SCOPUS:85133323226
SN - 0085-2538
VL - 102
SP - 405
EP - 420
JO - Kidney International
JF - Kidney International
IS - 2
ER -